ARMISTICE CAPITAL, LLC

Q2 2021 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2021
Date filed
8/16/2021
Form type
13F-HR
Num holdings
116
Total value ($000)
$5,586,566
Net value change ($000)
+1,231,122 (28.3%)
New positions
32
Sold out positions
30
Turnover %
34.3%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/17/2021 Next filing: 11/15/2021 SEC filing

Snapshot: Change Analysis

Compared to Q1 2021
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
IOVA 87,739 NEW
BURL 82,578 NEW
BIIB 46,859 58.2%
LULU 46,697 456.2%
TH 46,348 NEW
HOLX 42,167 NEW
HAE 41,583 NEW
WSM 41,059 NEW
ASO 38,160 NEW
VRTX 36,741 43.6%
Top Reduces (Value $000, Stocks/ETFs)
TJX -74,625 -100.0%
LNTH -57,699 -100.0%
AAP -50,179 -100.0%
NKE -42,856 -100.0%
RL -35,780 -100.0%
WMT -26,578 -46.3%
ADBE -25,670 -100.0%
TSCO -23,505 -100.0%
POST -19,875 -100.0%
Biohaven Pharmaceutical Holding Co Ltd. -19,810 -29.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 1,775,061 (31.8% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type